Results 261 to 270 of about 321,114 (362)

Editorial for the Genetics of Muscular Dystrophies from the Pathogenesis to Gene Therapy Special Issue. [PDF]

Genes (Basel), 2023
Politano L, Santorelli FM.
europepmc   +1 more source

Laevadosin in Muscular Dystrophy [PDF]

, 1965
J. N. Walton, S. S. Gubbay, P. Hudgson, D. J. Newell   +3 more
openalex   +1 more source

Mutations in COL6A Gene Family Responsible for Muscular Dystrophies in Three Unrelated Families. [PDF]

Iran Biomed J
Soltani N, Shahbazi Z, Karimipoor M, Fallah MS, Zafarghandi Motlagh F, Amini M, Jamali M, Bagherian H, Zeinali R, Zeinali S.   +9 more
europepmc   +1 more source

PAX7, a Key for Myogenesis Modulation in Muscular Dystrophies through Multiple Signaling Pathways: A Systematic Review. [PDF]

Int J Mol Sci, 2023
Rahman NIA, Lam CL, Sulaiman N, Abdullah NAH, Nordin F, Ariffin SHZ, Yazid MD.   +6 more
europepmc   +1 more source

Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Vasoreactivity of pulmonary arteries regulates blood flow through the lungs. Excessive constriction of these vessels contributes to pulmonary arterial hypertension (PAH), a progressive and incurable condition, resulting in right heart failure.
Adam L. Fellows, Kate Quigley, Venus Leung, Alexander J. Ainscough, Martin R. Wilkins, Harry Barnett, David Miller, Manuel Mayr, Beata Wojciak‐Stothard   +8 more
wiley   +1 more source

Prevalence of Duchenne and Becker Muscular Dystrophies in the United States

Pediatrics, 2015
P. Romitti, Yong Zhu, Soman Puzhankara, K. James, S. Nabukera, G. Zamba, E. Ciafaloni, C. Cunniff, C. Druschel, C. Druschel, K. Mathews, Dennis J. Matthews, F. Meaney, J. Andrews, K. Conway, D. Fox, N. Street, M. Adams, J. Bolen   +18 more
semanticscholar   +1 more source

TTN-Related Muscular Dystrophies, LGMD, and TMD, in an Estonian Family Caused by the Finnish Founder Variant. [PDF]

Neurol Genet
Õunap K, Reimand T, Õiglane-Shlik E, Puusepp S, Mihkla L, Pajusalu S, Savarese M, Udd B.   +7 more
europepmc   +1 more source

Sphingolipids mediate lipotoxicity in muscular dystrophies. [PDF]

Life Med, 2022
Wang Y, Shyh-Chang N.
europepmc   +1 more source

High‐throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin‐deficient limb girdle muscular dystrophy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Limb‐girdle muscular dystrophy R2 (LGMD R2) is a rare genetic disorder characterised by progressive weakness and wasting of proximal muscles. LGMD R2 is caused by the loss of function of dysferlin, a transmembrane protein crucial for plasma membrane repair in skeletal muscles.
Celine Bruge, Nathalie Bourg, Emilie Pellier, Johana Tournois, Jerome Polentes, Manon Benabides, Noella Grossi, Anne Bigot, Anthony Brureau, Isabelle Richard, Xavier Nissan   +10 more
wiley   +1 more source

THE METABOLISM OF CREATINE-1-C14 BY MICE WITH HEREDITARY MUSCULAR DYSTROPHY* [PDF]

, 1961
Coy D. Fitch, James D. Oates, James S. Dinning   +2 more
openalex   +1 more source